No Brainer Approaches to Pyoderma Gangrenosum and Sweet Syndrome
Pyoderma gangrenosum and Sweet syndrome are the most common neutrophilic dermatoses that a dermatologist will see in clinic, according to Dr. Anthony Fernandez, director of medical and inpatient dermatology at the Cleveland Clinic. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Fernandez, who shared criteria for making an accurate pyoderma gangrenosum dia …
Pyoderma gangrenosum and Sweet syndrome are the most common neutrophilic dermatoses that a dermatologist will see in clinic, according to Dr. Anthony Fernandez, director of medical and inpatient dermatology at the Cleveland Clinic. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Fernandez, who shared criteria for making an accurate pyoderma gangrenosum dia … Continue reading "No Brainer Approaches to Pyoderma Gangrenosum and Sweet Syndrome"
In the age of immunotherapy, is there a place for hedgehog inhibitors in cutaneous oncology?
ODAC Guest Advisor Dr. Vishal Patel says hedgehog inhibitors are even more important now. Dr. Patel spoke with Next Steps in Derm, in partnership with the ODAC Dermatology Conference, where he outlined scenarios in clinical treatment where hedgehog inhibitors make sense. Learn about the two approved m … 
Dermatologists know how to perform hidradenitis suppurativa deroofing – they just don’t know that they know how! That’s according to Dr. Steven Daveluy, professor and program director at Wayne State Dermatology. In an interview with Next Steps in Derm, in partnership with the ODAC Dermatology Conference, Dr. Daveluy shares his encouragement for dermatologists to try deroofing even if they we … 
Dr. Robyn Siperstein, a dermatologist in Boca Raton and Boynton Beach, Fla., credits a culture of service for the growth of her dermatology practice to more than 100 staff members at two locations. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Siperstein, who shared some of her early leadership lessons. Want to find more enjoyment in your work? Find out h … 
ODAC Co-Chair Dr. Adam Friedman says some nuanced changes in recently published scientific literature have changed the way he approaches rosacea. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Friedman, who addressed the latest understanding of rosacea triggers. Should your still tell your rosacea patients to avoid coffee? Find out what the latest researc …